Acadia Pharmaceuticals Inc
NASDAQ: ACAD
$16.37
+$0.19 (+1.2%)
Closing Price on November 22, 2024
ACAD Articles
Acadia Pharmaceuticals shares rose sharply early Monday after the firm announced that its late-stage dementia study met its primary endpoint.
Published:
Last Updated:
Acadia Pharmaceuticals shares dropped on Tuesday after the firm announced results from its late-stage study for the treatment of adult schizophrenia patients.
Published:
Last Updated:
Acadia Pharmaceuticals shares dipped on Wednesday despite announcing positive top-line results from its Clarity mid-stage study in major depressive disorder (MDD).
Published:
Last Updated:
Acadia Pharmaceuticals shares popped after the company announced that the FDA completed a postmarketing review and issued a clear statement reaffirming the positive benefit-risk profile of Nuplazid...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday include AMD, Alcoa, AT&T, Darden Restaurants, Micron Technology, New Age Beverages, Nike, Novavax, Pier 1 Imports and Under...
Published:
Last Updated:
With 2018 coming to a close in just a few months, Merrill Lynch is taking a close look at the biotech industry and what key catalysts to expect before 2019.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday include Aetna, Analog Devices, Lowe's, Merck, Pfizer, Plug Power, Qualcomm and Target.
Published:
Ultra Petroleum, Coty, e.l.f. Beauty, and Acadia Pharmaceuticals all posted new 52-week lows Thursday.
Published:
Last Updated:
24/7 Wall St. tracked six companies that saw three or more analyst downgrades or price target cuts on Thursday, August 9, 2018.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Thursday include Applied Materials, Extreme Networks, Mylan, NXP, Roku, Seagate, Yelp and Zynga.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Tuesday include Broadcom, CBS, Etsy, Illumina, PulteGroup, SeaWorld, Wynn Resorts and Zillow.
Published:
Last Updated:
Mannkind, Tesaro, Acadia Pharmaceuticals, and Diebold Nixdorf all posted new 52-week lows Monday.
Published:
Last Updated:
LendingClub, Coca-Cola, Acadia Pharmaceuticals, and Bristol-Myers Squibb all posted new 52-week lows Wednesday.
Published:
Last Updated:
Acadia Pharmaceuticals, Veo, Sibanye Gold, and Incyte Pharmaceuticals all posted new 52-week lows Monday.
Published:
Last Updated:
A new Merrill Lynch research report makes the case that four top biotech companies the firm covers have some powerful catalysts that could drive performance this year.
Published:
Last Updated: